RSPH vs XLV: Differences, Returns & Fees
Over the year to Nov 18, 2026, RSPH returned +29.7% to XLV's +20.7%; 53% of their weight is in the same names.
- Return gap
- +9.0 pts1 year to Nov 18, 2026: RSPH ahead, total return
- Fee gap
- 0.32 ptsA year: RSPH 0.40%, XLV 0.08%, per filings dated Jan 28, 2026 and Aug 27, 2026
- Overlap
- 53%Share of the two books held in common, holdings dated Nov 17, 2026
- Net flow
- +$93m / +$1.1bRSPH / XLV, Oct 19, 2026 to Nov 17, 2026, daily basis
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
RSPH +29.7%, XLV +20.7%: RSPH +9.0 pts ahead, 1 year, Nov 18, 2025 to Nov 18, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in RSPH costs about $3.50 one way and $7.00 in and out, at a median spread of 0.07%. The 0.07% spread is RSPH’s 30-day median, from Invesco (fund page).
Fees over time
Hypothetical. $10,000 in RSPH for 10 years at 0.40% a year costs about $664 in fees and lost growth; XLV at 0.08% would cost $135. Assumes 6% a year before fees, a sample rate, not a forecast.
Key numbers
XLV costs 0.32 points a year less; their one-year returns differ by 9.0 points; XLV is far larger, $49.6bn against $1.0bn.
Pair scorecard
Open the table
| Total return, 1 year | +29.7% | +20.7% |
|---|---|---|
| Below its high | 4.0%, high on Nov 4, 2026 | 4.5%, high on Nov 4, 2026 |
| What it tracks | S&P 500 Equal Weight Health Care Index | Health Care Select Sector Index |
| Expense ratio | 0.40% | 0.08% |
| Net assets, as of Nov 17, 2026 | $1.0bn | $49.6bn |
| Holdings in common | 53% | |
| Top ten holdings, share of the fund | 19.3% | 60.8% |
The numbers behind it
Net assets on Nov 17, 2026: $1.0bn for Invesco S&P 500 Equal Weight Health Care ETF and $49.6bn for State Street Health Care Select Sector SPDR ETF.
Holdings in common uses holdings dated Nov 17, 2026.
What they share
By the books each fund has filed, RSPH and XLV hold 53% of their money in the same securities at the same weight. Holdings dated Nov 17, 2026.
half
53% in common
Held in common
Show all 12 holdings
| Eli Lilly & Co | 1.88% | 16.87% |
| McKesson Corp | 1.84% | 1.90% |
| Intuitive Surgical Inc | 1.83% | 2.27% |
| Gilead Sciences Inc | 1.75% | 3.14% |
| Amgen Inc | 1.75% | 3.69% |
| AbbVie Inc | 1.75% | 7.71% |
| Thermo Fisher Scientific Inc | 1.70% | 3.78% |
| Medtronic PLC | 1.67% | 1.86% |
| Danaher Corp | 1.66% | 2.10% |
| Stryker Corp | 1.73% | 1.65% |
| Johnson & Johnson | 1.57% | 10.00% |
| Pfizer Inc | 1.56% | 2.42% |
Only in RSPH
Show all 2 holdings
| Invesco Government & Agency Portfolio | 0.03% |
| SECURITIES LENDING - BNYM | 0.00% |
Only in XLV
Show all 1 holdings
| XAV HEALTH CARE DEC26 | 0.02% |
Side by side
Open the table
| Fund | Invesco S&P 500 Equal Weight Health Care ETF | State Street Health Care Select Sector SPDR ETF |
| Where it sits | Stock ETF | Stock ETF |
| Issuer | Invesco | State Street |
| What it is | Tracks an index | Tracks an index of Health care |
| Total return, 1 year | +29.7% | +20.7% |
| Expense ratio | 0.40% | 0.08% |
| Already in the S&P 500 | 100.0% | 99.8% |
| Holdings | 63 | 62 |
| Net assets, as of Nov 17, 2026 | $1.0bn | $49.6bn |
RSPH and XLV on the fields both publish, as of Nov 18, 2026. Source: ETFIQ.
From Nov 2006 to Nov 2026, RSPH returned more: +840.0% to +698.2%. XLV swung slightly less: 16.6% to 18.0%. XLV fell slightly less at its worst: −37.9% to −39.5%.
Full scorecard
Open the table
| Total return | +840.0% | +698.2% | RSPH | Price change plus distributions, reinvested. |
| Annualized | +11.8% | +10.9% | RSPH (slight) | Total return as a yearly rate. |
| Price return | +731.8% | +465.4% | RSPH | Price change alone, distributions left out. |
| Volatility | 18.0% | 16.6% | XLV (slight) | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 12.8% | 11.8% | XLV (slight) | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −39.5% | −37.9% | XLV (slight) | Deepest fall from a high to the low after it. |
| Sharpe | 0.62 | 0.61 | RSPH (slight) | Return above Treasury bills per unit of volatility. |
| Sortino | 0.87 | 0.86 | Tie | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.30 | 0.29 | RSPH (slight) | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,043 weekly returns. Cash rate: the 13-week Treasury bill.
About RSPH
RSPH tracks an index. Over the year to Nov 18, 2026 it returned +29.7% with distributions reinvested.
More
The prospectus expense ratio is 0.40% a year. By its holdings published by its issuer for Nov 17, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 63 positions, with the top ten at 19.3%. It sat 4.0% below its high of Nov 4, 2026 on Nov 18, 2026.
About XLV
XLV tracks an index of Health care. Over the year to Nov 18, 2026 it returned +20.7% with distributions reinvested.
More
The prospectus expense ratio is 0.08% a year. By its holdings published by its issuer for Nov 17, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 62 positions, with the top ten at 60.8%. It sat 4.5% below its high of Nov 4, 2026 on Nov 18, 2026.
Questions people ask
Which returned more over the last year, RSPH or XLV?
In the year to Nov 18, 2026, with distributions reinvested, RSPH returned +29.7% and XLV +20.7%.
Which is cheaper, RSPH or XLV?
XLV is cheaper, by 0.32 percentage points a year. That is about $32 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, RSPH against XLV, data as of Nov 18, 2026. https://etfiq.com/compare/any/rsph-vs-xlv
ETFIQ. (Nov 18, 2026). RSPH against XLV. Retrieved from https://etfiq.com/compare/any/rsph-vs-xlv
[RSPH against XLV (ETFIQ, Nov 18, 2026)](https://etfiq.com/compare/any/rsph-vs-xlv)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.